Meeting spend holding steady

As pharmaceutical companies cut spending on other  marketing areas, meetings stay a primary channel for gaining physician mindshare, data show.

Group events, from international conferences to local dinner meetings to in-office seminars, have held at around 7% of total marketing spend over the last several years, according to a report from Cegedim Strategic Data that tracked spend through the first quarter of 2011.

A big increase came in dinner meetings: “International and national conferences are not getting the same kind of support or participation that local ones are,” said Jerry Maynor, US marketing and business development director at the company.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.